This message was sent to ##Email##
|
|
|
|
|
|
Advertisement
|
|
|
| |
The Wall Street Journal
Looking for a genetic link to pediatric cancers reflects expanding efforts to match adult and child patients with drugs that target specific mutations found to drive growth of their tumors. By analyzing DNA not only from a diagnosed child's tumor cells but also normal DNA from blood or skin tissue from the child and other family members, doctors can determine whether the cancer is likely to be unique to the child, or if a potentially cancer-causing mutation is lurking in the family.
READ MORE
Over the past few months, the AJCC held five disease site webinars (Melanoma, Lung, Breast, Colorectum and Prostate) based on the AJCC Seventh Edition. For people unable to attend the live programs, the AJCC will provide free recordings of each webinar. Include with the webinar are pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
To view the recordings or to learn more about the Disease Site webinars and stay informed go to the AJCC website.
|
Promoted by
|
|
|
|
 |
CBS News
Spitting in a tube for science is what unites a growing group of breast cancer patients taking part in a unique project to advance treatment for the deadliest form of the disease.
For many of the 150,000-plus patients nationwide whose tumors have spread to bones, brains, lungs or other distant organs, the hue heralding breast cancer awareness and survival each October is a little too rosy. They know cancer will likely kill them. And they've often felt neglected by mainstream advocacy and medical research.
But now they have a way to get involved, with a big new project that aims to gather enormous troves of information about their diseases in hopes of finding new and better ways of treating patients like them.
READ MORE
Medical News Today
Last year, a controversial study suggested the majority of cancer cases are down to "bad luck" — that is, random DNA mutations in adult stem cells that are not caused by lifestyle factors. A new study contradicts this claim; while bad luck does play a role cancer development, researchers find it is unlikely to be the primary contributor.
READ MORE
 |
|
prIME Patients is prIME Oncology’s resource center for patients with cancer and their caregivers. Our patient-focused videos explain, in layman’s terms, how certain treatments fight the various cancers. This information will arm you with the knowledge on what to expect during your course treatment so that you can be an informed part of the decision making team.
|
|
CoC - NAPBC
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage you to promote Breast Cancer Awareness Month and use it as an opportunity to display and publicize your program's accreditation status with the CoC and NAPBC.
The NAPBC and the CoC have created a poster to use within your program and community.
How to access the poster:
Programs that are accredited solely by the NAPBC, use the Marketing Resources website link that was provided in your performance report email notification.
Programs that are accredited solely by the CoC or both the CoC and NAPBC, go to CoC Datalinks and click on Marketing Resources.
Please let us know about your celebration by sending photos and event information to Susan Rubin, business development manager, ACS Cancer Programs.
READ MORE
|
Promoted by
|
|
|
|
 |
Medscape
A combination of biomarkers could be used in noninvasive screening for pancreatic cancer in patients with new-onset diabetes, suggests new research presented at this year's European Association for the Study of Diabetes 2016 Annual Meeting.
"This approach would both reduce the delay in diagnosis of pancreatic cancer and improve the prognosis of diabetic patients with this malignant disease," said lead author of the study, Pavel Škrha, M.D., from Charles University, Prague, Czech Republic.
READ MORE
News-Medical.Net
Radiation therapy is the main treatment modality in the management of head and neck cancer. Due to the close proximity of many important normal structures, radiotherapy can result in severe acute and late toxicities, particularly long-term xerostomia and feeding tube dependency. A pooled analysis of data from NRG Oncology studies RTOG 0129 and 0522 compared intensity-modulated radiotherapy with three-dimensional conformal radiotherapy for patients treated for locally advanced head and neck squamous cell carcinoma.
READ MORE
CoC
The Commission on Cancer is hosting a paper competition for physicians-in-training to foster the importance of oncologic research in support of its mission. Papers are due June 30, 2017.
READ MORE
University of Washington via Medical Xpress
Short, unstable stretches of DNA, called microsatellites, may play a far greater role in the development and progression of cancer than previously thought, UW Medicine researchers report in a study appearing Oct. 3 in the journal Nature Medicine. "These findings give us new insights into the basic biology of cancer and open opportunities for new ways to type and potentially treat a wide variety of cancers," said senior author Stephen J. Salipante, University of Washington assistant professor of laboratory medicine.
READ MORE
News-Medical.Net
The development of oral cancer drugs as a modality therapy over the last decade has highlighted the problem of non-adherence. Only cancer drugs that are taken can actually work. Contrary to what is expected, a significant number of cancer patients doesn't take their cancer drugs as prescribed. The results of a new study on the "impact of cognitive functions on oral anticancer therapies adherence," designed by Professor Florence Joly and Dr. Melanie Dos Santos of the Centre Francois Baclesse in Caen and presented at the ESMO Congress 2016, highlights that cognitive disorders may be an under-estimated major parameter (notably among elderly patients).
READ MORE
AJCC
If you are at Clinical Congress, attend the ACS Theatre session on the new AJCC Cancer Staging Manual, Eighth Edition. The New AJCC TNM Staging System: Vision, What's New, and Preparing for Implementation will be presented by Editor-in-Chief Mahul Amin, MD, FCAP, who will provide an overview of the staging changes that go into effect Jan. 1, 2017. His presentation will cover the new staging systems, unique paradigms for existing systems, updated General Staging rules, prognostic factors and AJCC-endorsed risk-assessment models. The presentation will be on Tuesday, Oct. 18 from 11:15 to 11:40 a.m. at the Theatre in the Exhibit Hall.
The AJCC Cancer Staging Manual, Eighth Edition, is scheduled for release at the end of October 2016.
READ MORE
The Washington Post
The idea of using the body's immune system to fight cancer has been around for a century, but only in the past half a dozen years have dramatic breakthroughs begun rocking the medical world.
"That's when the tsunami came," says Drew Pardoll, director of the Bloomberg-Kimmel Institute for Cancer Immunology at Johns Hopkins University, and those advances are spawning hundreds of clinical trials nationwide, plus generating intense interest from patients, physicians and investors. Yet researchers remember the past anti-cancer efforts that fizzled after initially showing promise — which explains why most say daunting hurdles and years of perseverance are still ahead.
Here's a primer about the new treatments and how they work.
READ MORE
NAPBC
Pursuing Excellence through NAPBC Accreditation will be held in Chicago on Nov. 12. Attend this workshop and learn how to develop and operate a high-quality breast center. Designed for members of the multidisciplinary breast healthcare team (for example, physicians, nurses, administrators), this program taught by experienced NAPBC committee members, board members, surveyors and staff explains how to use the NAPBC standards as a framework for developing a high-quality breast center and your role prior to, during and after the NAPBC accreditation survey.
READ MORE
For additional information, please complete the mailing list request form.
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
